Supply of nuclear medicine radiopharmaceuticals, Mo/Tc generators and isotopes, including 223-Ra dichloride (Xofigo)

Summary

The tender concerns the supply of nuclear medicine radiopharmaceuticals, Mo/Tc generators and isotopes for scintigraphy examinations and therapy procedures, including 223-Ra dichloride (Xofigo). The procurement is divided into 16 lots, and a bidder may submit one tender for one or more lots, but no alternative tenders are permitted. The planned contract value is up to EUR 1,000,000 excluding VAT. The contract will run for 24 months or until the contract value is reached, with a possible extension of up to 12 months if the value is not reached. The contract is performed at the Latvian Oncology Centre in Riga. The award criterion is the lowest total price per position, excluding VAT. Tenders must be submitted electronically through the Latvian electronic procurement system by 18 September 2026. A bid guarantee is not required.